LCID
Lucid Group, Inc.
LCID offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
MLR
Miller Industries, Inc.
MLR has a slight edge over LCID overall, supported by lower modeled downside and stronger modeled upside.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
MLR Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Strong |
MLR's cash flow and balance sheet are currently strong, and its revenue and profitability are stable.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
MLR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.6x | $14.45 | -70% |
| Fair | 14x | $20.88 | -57% |
| Forward | 17x | $48.71 | — |
| Expensive | 21x | $31.75 | -35% |
| Current | 32x | $48.71 | — |
Historical ranges are pointers, not guarantees.
MLR's PE is in its expensive range at 32x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
MLR Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| High |
Analysts expect strong earnings and revenue growth for MLR, with profitability improving.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
MLR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.85 | +90% |
| Q3 2026 | $1.50 | -42% |
| Q2 2026 | $1.24 | -66% |
| Q1 2026 | $1.34 | -71% |
| Q4 2025 | $1.98 | -64% |
| Q3 2025 | $2.58 | -57% |
| Q2 2025 | $3.64 | -41% |
| Q1 2025 | $4.69 | -18% |
| Q4 2024 | $5.47 | +7.9% |
MLR has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over MLR on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
MLR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $212.2M | +19% |
| Q2 2026 | $240M | +12% |
| Q1 2026 | $180.9M | -20% |
| Q4 2025 | $171.9M | -23% |
| Q3 2025 | $178.7M | -43% |
| Q2 2025 | $214M | -42% |
| Q1 2025 | $225.7M | -36% |
| Q4 2024 | $221.9M | -25% |
MLR's revenue is recovering but still below its 2024 peak: $212M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +1.1 points |
| Q2 2026 | 4.2% | -1.1 points |
| Q1 2026 | 0.9% | -3.9 points |
| Q4 2025 | 2.9% | -2.8 points |
| Q3 2025 | 2.4% | -3.9 points |
| Q2 2025 | 5.3% | -1.8 points |
| Q1 2025 | 4.8% | -1.4 points |
| Q4 2024 | 5.7% | -1.4 points |
MLR has the edge over LCID on profitability, with a higher operating margin.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
MLR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $13.7M | -25% |
| Q2 2026 | $28M | +9.7% |
| Q1 2026 | $22.8M | +$25.2M |
| Q4 2025 | $43.8M | +$56.7M |
| Q3 2025 | $18.1M | -25% |
| Q2 2025 | $25.6M | +$39.4M |
| Q1 2025 | -$2.4M | -156% |
| Q4 2024 | -$13M | -396% |
MLR has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
MLR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -36.5K shares |
| 1 year | -0.9% | -110K shares |
| 3 years | -0.3% | -30K shares |
| 5 years | +0.6% | +74K shares |
| Available history | +0.7% | +85K shares |
MLR has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.7M |
| Q2 2026 | $2.5M |
| Q1 2026 | $2.2M |
| Q4 2025 | $2.2M |
| Q3 2025 | $1.2M |
| Q2 2025 | $500,000 |
| Q1 2025 | $2.1M |
| Q4 2024 | — |
MLR spent $10M buying back its own shares over the past year, up 155% from the year before.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
MLR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.4x | Net Cash |
| Q1 2026 | -0.8x | Net Cash |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | 0.3x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.4x | Very low |
MLR has more cash than debt.
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
MLR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.5 | Neutral |
| Stochastic | 20.2 | Neutral |
MLR's weekly RSI is 45 (neutral) and its Stochastic is 20 (neutral).
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
MLR PE vs Consumer Cyclical Sector
| Metric | MLR | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 18x | 80% above |
| PE % | 93 | 47 | 46 pts above |
MLR is trading at 32x earnings, a 80% premium to the Consumer Cyclical sector's median of 18x.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
MLR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $51.2 | 4.9% below |
| 20 week MA | $52.5 | 7.1% below |
| 50 week MA | $47.6 | 2.4% above |
| 100 week MA | $47.3 | 3% above |
| 200 week MA | $46.8 | 4.2% above |
MLR has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.
MLR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.2 | $36.8 | -1% |
| 2021 | $36.8 | $32.5 | -12% |
| 2022 | $32.5 | $26.4 | -19% |
| 2023 | $26.4 | $42.3 | +60% |
| 2024 | $42.3 | $65.7 | +55% |
| 2025 | $65.7 | $38.2 | -42% |
| 2026 YTD | $38.2 | $48.7 | +28% |
MLR has the edge over LCID on returns for 2026, with the stronger performance.